Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Circulating Tumor Cells in Breast Cancer Patients

Volumen 21, Ausgabe 1-2, 2016, pp. 125-139
DOI: 10.1615/CritRevOncog.2016016120
Get accessGet access

ABSTRAKT

Breast cancer is the most commonly diagnosed cancer among women, resulting in an estimated 40,000 deaths in 2014.1 Metastasis, a complex, multi-step process, remains the primary cause of death for these patients. Although the mechanisms involved in metastasis have not been fully elucidated, considerable evidence suggests that metastatic spread is mediated by rare cells within the heterogeneous primary tumor that acquire the ability to invade into the bloodstream. In the bloodstream, they can travel to distant sites, sometimes remaining undetected and in a quiescent state for an extended period of time before they establish distant metastases in the bone, lung, liver, or brain. These occult micrometastatic cells (circulating tumor cells, CTCs) are rare, yet their prognostic significance has been demonstrated in both metastatic and non-metastatic breast cancer patients. Because repeated tumor tissue collection is typically not feasible and peripheral blood draws are minimally invasive, serial CTC enumeration might provide "real-time liquid biopsy" snapshots that could be used to identify early-stage breast cancer patients with micrometastatic disease who are at risk for disease progression and monitor treatment response in patients with advanced disease. In addition, characterizing CTCs might aid in the development of novel, personalized therapies aimed at eliminating micrometastases. This review describes current CTC isolation, detection, and characterization strategies in operable breast cancer.

REFERENZIERT VON
  1. Feng Yixiao, Spezia Mia, Huang Shifeng, Yuan Chengfu, Zeng Zongyue, Zhang Linghuan, Ji Xiaojuan, Liu Wei, Huang Bo, Luo Wenping, Liu Bo, Lei Yan, Du Scott, Vuppalapati Akhila, Luu Hue H., Haydon Rex C., He Tong-Chuan, Ren Guosheng, Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis, Genes & Diseases, 5, 2, 2018. Crossref

  2. Chrabaszcz Karolina, Jasztal Agnieszka, Smęda Marta, Zieliński Bartosz, Blat Aneta, Diem Max, Chlopicki Stefan, Malek Kamilla, Marzec Katarzyna M., Label-free FTIR spectroscopy detects and visualizes the early stage of pulmonary micrometastasis seeded from breast carcinoma, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1864, 11, 2018. Crossref

  3. Zubor Pavol, Kubatka Peter, Kajo Karol, Dankova Zuzana, Polacek Hubert, Bielik Tibor, Kudela Erik, Samec Marek, Liskova Alena, Vlcakova Dominika, Kulkovska Tatiana, Stastny Igor, Holubekova Veronika, Bujnak Jan, Laucekova Zuzana, Büsselberg Dietrich, Adamek Mariusz, Kuhn Walther, Danko Jan, Golubnitschaja Olga, Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management, International Journal of Molecular Sciences, 20, 12, 2019. Crossref

  4. Liang Diana H., Hall Carolyn, Lucci Anthony, Circulating Tumor Cells in Breast Cancer, in Tumor Liquid Biopsies, 215, 2020. Crossref

  5. Nixon Nancy A., Simmons Christine, Lemieux Julie, Verma Sunil, Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting Partnership, The Breast Journal, 26, 3, 2020. Crossref

  6. Jha Niraj Kumar, Jha Saurabh Kumar, Sharma Ankur, Yadav Rahul, Pandey Pratibha, Kesari Kavindra Kumar, Kumar Neeraj, Nand Parma, Agrahari Mansi, Gupta Nancy Sanjay, Clinical Relevance of “Biomarkers” in Cancer Metabolism, in Cancer Cell Metabolism: A Potential Target for Cancer Therapy, 2020. Crossref

  7. Bittner Ann‐Kathrin, Keup Corinna, Hoffmann Oliver, Hauch Siegfried, Kimmig Rainer, Kasimir‐Bauer Sabine, Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple‐negative breast cancer patients, Journal of Cellular and Molecular Medicine, 24, 15, 2020. Crossref

  8. Presta Ivan, Novellino Fabiana, Donato Annalidia, La Torre Domenico, Palleria Caterina, Russo Emilio, Malara Natalia, Donato Giuseppe, UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy, International Journal of Molecular Sciences, 21, 6, 2020. Crossref

  9. Jin Lidan, Zhao Wenhe, Zhang Jun, Chen Wenjun, Xie Tan, Wang Linbo, Fan Wanhung, Xie Shuduo, Shen Jianguo, Zheng Heming, Hu Wenxian, Wei Qun, Dong Minjun, Wang Qinchun, Shen Jun, Liu Yongcheng, Evaluation of the diagnostic value of circulating tumor cells with CytoSorter ® CTC capture system in patients with breast cancer , Cancer Medicine, 9, 5, 2020. Crossref

  10. Wen Zunbei , Li Zhongtai , Yong Pangxiao , Liang Dunbo , Xie Di , Chen Haiwen , Yang Yongying , Wu Shiyang , Li Cong , Cheng Zhen , Detection and clinical significance of circulating tumor cells in patients with nasopharyngeal carcinoma, Oncology Letters, 2019. Crossref

  11. Wu Yanlin , Meng Qiping , Yang Zhixue , Shi Lili , Hu Rongkuan , Zhang Peizhuo , Wei Jinrong , Ren Jie , Leng Bingjing , Xu Dong , Jiang Guo‑Qin , Circulating HER‑2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer, Oncology Letters, 2018. Crossref

  12. Meijer Suzy, Klebanov-Akopyan Olga, Pavlov Vera, Laks Shachar, Hazzan David, Nissan Aviram, Zippel Douglas, Detection of Minimal Residual Disease in the Peripheral Blood of Breast Cancer Patients, with a Multi Marker (MGB-1, MGB-2, CK-19 and NY-BR-1) Assay, Breast Cancer: Targets and Therapy, Volume 13, 2021. Crossref

  13. Ramos-Medina Rocío, López-Tarruella Sara, del Monte-Millán María, Massarrah Tatiana, Martín Miguel, Technical Challenges for CTC Implementation in Breast Cancer, Cancers, 13, 18, 2021. Crossref

  14. Mäurer Matthias, Pachmann Katharina, Wendt Thomas, Schott Dorothea, Wittig Andrea, Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients, Current Oncology, 28, 5, 2021. Crossref

  15. Pozniak T. A., Hancharou A. Y., Abashkin V. M., Stanovaya A. I., Prokhorov A. V., Shcharbin D. G., Circulating tumor cells and circulating cancer stem cells and their detection by the method of flow cytometry, Proceedings of the National Academy of Sciences of Belarus, Biological Series, 66, 3, 2021. Crossref

  16. Tong Bing, Wang Mengzhao, Circulating tumor cells in patients with lung cancer: developments and applications for precision medicine, Future Oncology, 15, 21, 2019. Crossref

  17. Seely Kevin D., Morgan Amanda D., Hagenstein Lauren D., Florey Garrett M., Small James M., Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia, Cancers, 14, 4, 2022. Crossref

  18. Chen Junyue, Oudeng Gerile, Feng Hongtao, Liu Sixi, Li Hung‐Wing, Ho Yi‐Ping, Chen Yan, Tan Ying, Yang Mo, 2D MOF Nanosensor‐Integrated Digital Droplet Microfluidic Flow Cytometry for In Situ Detection of Multiple miRNAs in Single CTC Cells, Small, 18, 32, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain